Literature DB >> 10954576

Detection and quantification of CD4(+) T cells with specificity for a new major histocompatibility complex class II-restricted influenza A virus matrix protein epitope in peripheral blood of influenza patients.

T Linnemann1, G Jung, P Walden.   

Abstract

FVFTLTVPS was identified as the core sequence of a new major histocompatibility complex class II-restricted T-cell epitope of influenza virus matrix protein. Epitope-specific CD4(+) T cells were detected in the peripheral blood of patients with frequencies of up to 0.94%, depending on the number of additional terminal amino acids.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10954576      PMCID： PMC116386          DOI： 10.1128/jvi.74.18.8740-8743.2000

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  28 in total

1.  MHC class II tetramers identify peptide-specific human CD4(+) T cells proliferating in response to influenza A antigen.

Authors:  E J Novak; A W Liu; G T Nepom; W W Kwok
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

2.  Processing pathways for presentation of cytosolic antigen to MHC class II-restricted T cells.

Authors:  M S Malnati; M Marti; T LaVaute; D Jaraquemada; W Biddison; R DeMars; E O Long
Journal:  Nature       Date:  1992-06-25       Impact factor: 49.962

Review 3.  Antigen presentation: structural themes and functional variations.

Authors:  T J Braciale; V L Braciale
Journal:  Immunol Today       Date:  1991-04

4.  Class II-restricted presentation of a hen egg lysozyme determinant derived from endogenous antigen sequestered in the cytoplasm or endoplasmic reticulum of the antigen presenting cells.

Authors:  A G Brooks; J McCluskey
Journal:  J Immunol       Date:  1993-05-01       Impact factor: 5.422

5.  Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen.

Authors:  V Pinet; M S Malnati; E O Long
Journal:  J Immunol       Date:  1994-05-15       Impact factor: 5.422

6.  Class II MHC-restricted T cell determinants processed from either endosomes or the cytosol show similar requirements for host protein transport but different kinetics of presentation.

Authors:  C J Hackett; J W Yewdell; J R Bennink; M Wysocka
Journal:  J Immunol       Date:  1991-05-01       Impact factor: 5.422

7.  Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients.

Authors:  P P Lee; C Yee; P A Savage; L Fong; D Brockstedt; J S Weber; D Johnson; S Swetter; J Thompson; P D Greenberg; M Roederer; M M Davis
Journal:  Nat Med       Date:  1999-06       Impact factor: 53.440

8.  Overlapping epitopes that are recognized by CD8+ HLA class I-restricted and CD4+ class II-restricted cytotoxic T lymphocytes are contained within an influenza nucleoprotein peptide.

Authors:  B M Carreno; R V Turner; W E Biddison; J E Coligan
Journal:  J Immunol       Date:  1992-02-01       Impact factor: 5.422

9.  An immunodominant class I-restricted cytotoxic T lymphocyte determinant of human immunodeficiency virus type 1 induces CD4 class II-restricted help for itself.

Authors:  H Takahashi; R N Germain; B Moss; J A Berzofsky
Journal:  J Exp Med       Date:  1990-02-01       Impact factor: 14.307

10.  An endogenous processing pathway in vaccinia virus-infected cells for presentation of cytoplasmic antigens to class II-restricted T cells.

Authors:  D Jaraquemada; M Marti; E O Long
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307
View more
  7 in total

Review 1.  Development of universal influenza vaccines based on influenza virus M and NP genes.

Authors:  M Zheng; J Luo; Z Chen
Journal:  Infection       Date:  2013-11-01       Impact factor: 3.553

2.  Assessment of seasonal influenza A virus-specific CD4 T-cell responses to 2009 pandemic H1N1 swine-origin influenza A virus.

Authors:  Xinhui Ge; Venus Tan; Paul L Bollyky; Nathan E Standifer; Eddie A James; William W Kwok
Journal:  J Virol       Date:  2010-01-13       Impact factor: 5.103

3.  A fluorescence polarization immunoassay for the rapid detection of antibody against influenza A virus in chicken and goat sera.

Authors:  Yohei Takeda; Yutaka Yonezawa; Satoshi Asake; Haruko Ogawa; Kunitoshi Imai
Journal:  J Vet Diagn Invest       Date:  2020-10-07       Impact factor: 1.279

4.  Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals.

Authors:  Laurel Yong-Hwa Lee; Do Lien Anh Ha; Cameron Simmons; Menno D de Jong; Nguyen Van Vinh Chau; Reto Schumacher; Yan Chun Peng; Andrew J McMichael; Jeremy J Farrar; Geoffrey L Smith; Alain R M Townsend; Brigitte A Askonas; Sarah Rowland-Jones; Tao Dong
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

5.  Circulating Type-1 Anti-Tumor CD4(+) T Cells are Preferentially Pro-Apoptotic in Cancer Patients.

Authors:  Amy K Wesa; Maja Mandic; Jennifer L Taylor; Stergios Moschos; John M Kirkwood; William W Kwok; James Harold Finke; Walter J Storkus
Journal:  Front Oncol       Date:  2014-09-29       Impact factor: 6.244

6.  Disease-associated bias in T helper type 1 (Th1)/Th2 CD4(+) T cell responses against MAGE-6 in HLA-DRB10401(+) patients with renal cell carcinoma or melanoma.

Authors:  Tomohide Tatsumi; Lisa S Kierstead; Elena Ranieri; Loreto Gesualdo; Francesco P Schena; James H Finke; Ronald M Bukowski; Jan Mueller-Berghaus; John M Kirkwood; William W Kwok; Walter J Storkus
Journal:  J Exp Med       Date:  2002-09-02       Impact factor: 14.307

7.  Human CD4(+) memory T-lymphocyte responses to SARS coronavirus infection.

Authors:  Daniel H Libraty; Kimberly M O'Neil; Lauren M Baker; Luz P Acosta; Remigio M Olveda
Journal:  Virology       Date:  2007-08-13       Impact factor: 3.616
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.